Body Dysmorphic Disorder Clinical Trial
Official title:
Online Cognitive Behavioural Therapy (CBT) Intervention for Body Dysmorphic Disorder: Comparison of CBT - Mindfulness to CBT Alone
Body Dysmorphic Disorder (BDD) affects 2.3% of the population and is characterized by excessive concerns with imagined or minor defects in physical appearance. Retrospective outcome studies suggest patients affected by BDD don't typically benefit from surgical treatments while cognitive behaviour therapy (CBT) appears to provide symptom - reducing and distress - reducing benefits. Two different 8-week online CBT approaches to assisting individuals with this disorder are compared: one approach will integrate mindfulness meditation methods (in combination with CBT) and one approach will employ CBT methods without reference to mindfulness meditation.
Body Dysmorphic Disorder (BDD) affects 2.3% of the population and is characterized by excessive concerns with imagined or minor defects in physical appearance. Retrospective outcome studies suggest patients affected by BDD typically do not benefit from surgical treatments while cognitive behaviour therapy (CBT) appears to provide symptom - reducing and distress - reducing benefits. In this study two different 8-week online CBT approaches to assist individuals with this disorder are compared: one approach will integrate mindfulness meditation methods (in combination with CBT) and one approach will employ CBT methods without reference to mindfulness meditation. The purpose of this comparison is to ascertain whether the inclusions of the two additional intervention modalities, demonstrated effective in other studies, adds to positive outcome effects in this disorder. A primary hypothesis is that the 8 week post-intervention outcomes associated with the CBT-mindfulness approach will show significantly more benefit than the comparison group. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02635152 -
Interpretation Bias Modification for Body Dysmorphic Disorder
|
N/A | |
| Completed |
NCT03673046 -
Waitlist-Control Trial of Smartphone Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder (BDD)
|
N/A | |
| Withdrawn |
NCT02843451 -
Milk Thistle in Body Dysmorphic Disorder
|
Phase 2 | |
| Completed |
NCT02010619 -
Internet Delivered CBT for Body Dysmorphic Disorder
|
N/A | |
| Completed |
NCT00842309 -
D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder
|
Early Phase 1 | |
| Completed |
NCT00245635 -
Fluoxetine in Pediatric Body Dysmorphic Disorder
|
Phase 4 | |
| Completed |
NCT02808702 -
Brain Correlates of Self-Focused Processing
|
N/A | |
| Completed |
NCT01002326 -
Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder
|
N/A | |
| Active, not recruiting |
NCT01075672 -
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
|
N/A | |
| Completed |
NCT02671266 -
Oxytocin Administration in BDD and OCD
|
Phase 2 | |
| Completed |
NCT01038128 -
An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
|
N/A | |
| Completed |
NCT01398865 -
Escitalopram Neuroimaging Supplement
|
N/A | |
| Completed |
NCT00265109 -
Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder
|
Phase 4 | |
| Recruiting |
NCT04373629 -
Perceptual Abnormalities and Their Malleability in BDD
|
N/A | |
| Completed |
NCT01453439 -
Cognitive-Behavioral Therapy and Supportive Psychotherapy for Body Dysmorphic Disorder
|
N/A | |
| Completed |
NCT00871143 -
Cognitive Behaviour Therapy (CBT) for Body Dysmorphic Disorder (BDD)
|
N/A | |
| Completed |
NCT00106223 -
Treatment Study Investigating New Cognitive Behavioral Therapy Treatment Manual for Body Dysmorphic Disorder
|
N/A | |
| Active, not recruiting |
NCT00211809 -
CBT as an Adjunct to SRIs in the Treatment of BDD
|
Phase 4 |